Ethics declarations Conflict of interest F.C.S declares grants from NIH/NIDDK (P30 DK040561, U24 DK132733, and UE5 DK137285) and consulting fees from Eli Lilly, Novo Nordisk, Amgen, Boehringer Ingelheim, AstraZeneca, AbbVie, Currax, Pfizer, Doximity, MelliCell, Vida Health, Empros Pharma, Apnimed, Clearmind Medicine, and Ilant Health, all outside of the current work
Fat Loss: Promotes fat reduction while preserving lean muscle mass
Visual indicators include cloudiness in reconstituted solution, unusual coloration, or in lyophilized form, visible moisture absorption the powder appears wet or clumped
Treatment should be provided within specialist weight management services and is usually limited to 2 years
Luminogenic materials constructed from tetraphenylethene building blocks: Synthesis, aggregation-induced emission, two-photon absorption, light refraction and explosive detection